Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

Common acne treatments can cause various side effects, like skin irritation and more serious issues, but combination therapies are often more effective and better tolerated.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

More adolescent girls in urban areas of India have Polycystic Ovary Syndrome compared to those in rural areas.

Different diagnostic criteria greatly affect PCOS diagnosis rates in teenagers.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

PCOS lowers quality of life, causing issues like obesity, infertility, and menstrual problems.

The conclusion is that a thorough approach is needed to diagnose and manage hyperandrogenism in teenage girls, recognizing its major psychological and health effects.

Menopause can cause skin issues, and seeing a dermatologist helps.

Polycystic ovary syndrome (PCOS) is a major health issue for women in Egypt, affecting 14% of fertile women and 37.5% of infertile women.

Most women with PCOS use positive coping strategies, but some with more psychological stress use negative ones.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Using rodents for research shows that health problems in the womb can cause diseases later in life.

Metformin improved menstrual cycle regularity and signs of hyperandrogenism in adolescent girls with type 1 diabetes but did not improve blood sugar control.

Hair loss led to the diagnosis of Cushing's disease in a patient, showing that hair loss can be a sign of hormonal disorders.

The document concludes that early and personalized treatment for PCOS in adolescents is crucial to manage symptoms and prevent long-term health issues.

A 33-year-old woman with PCOS and metabolic syndrome was unusually diagnosed with a bone condition called DISH, suggesting a possible link between these conditions.

Medications for PCOS don't seem to raise heart disease risk.

The study concluded that a higher waist-hip ratio significantly increases the risk of metabolic syndrome in women with PCOS.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

The GH-IGF-I axis is likely involved in the hormonal imbalances seen in non-obese women with functional hyperandrogenism.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

About 40% of women by age 60 experience significant hair loss, often due to androgenetic alopecia, with treatments like minoxidil available and hope for future cures.

Early detection and comprehensive treatment of PCOS are crucial due to its long-term health impacts and associated risks.

Adult female acne is a complex condition that can worsen with menopause, requiring holistic treatment and tailored skincare at different life stages.